Baclofen for Alcohol Abstinence in Patients with Psychotic Symptoms

Role of Baclofen in Alcohol Abstinence

The American Association for the Study of Liver Diseases recommends baclofen (30-80 mg/day) for maintaining abstinence in patients with alcoholic liver disease and cirrhosis, where it has demonstrated both safety and efficacy 1, 2, 3
Baclofen works as a GABAB receptor agonist that reduces alcohol craving and maintains abstinence over 12-week treatment periods, according to the Clinical and Molecular Hepatology 1, 3

The European Association for the Study of the Liver considers baclofen safe in patients with alcoholic liver disease and cirrhosis, making it the preferred pharmacological option in this population 3
Randomized trials specifically in cirrhotic patients have demonstrated both safety and efficacy for promoting abstinence, as reported by Praxis Medical Insights 3

The standard dosing range is 30-80 mg/day, with 80 mg/day being the maximum recommended dose with marketing authorization, according to Praxis Medical Insights 3
For patients with severe liver disease, use more gradual dose titration, as recommended by Praxis Medical Insights 3

The American College of Clinical Pharmacology recommends haloperidol (0.5-5 mg PO every 8-12 hours or 2-5 mg IM) as adjunctive therapy for agitation or psychotic symptoms such as hallucinations that are not controlled by benzodiazepines during acute withdrawal 1
The management algorithm for patients with psychotic symptoms includes using benzodiazepines as first-line for withdrawal symptoms, adding haloperidol specifically for psychotic symptoms, and initiating baclofen for abstinence maintenance once withdrawal symptoms have resolved 1, 3

The National Institute on Alcohol Abuse and Alcoholism recommends combining baclofen with psychosocial interventions, including individual psychotherapy, psychoeducation, group therapy, and cognitive behavioral therapy 2, 3
All patients with alcohol use disorder require thiamine supplementation (100-300 mg/day for 4-12 weeks) to prevent Wernicke encephalopathy, as recommended by the Clinical and Molecular Hepatology and Praxis Medical Insights 1, 2